Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 11 | 2025 | 1214 | 1.530 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2023 | 27 | 0.940 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2022 | 4 | 0.760 |
Why?
|
| Papilloma, Intraductal | 1 | 2022 | 6 | 0.760 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 35 | 0.740 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2020 | 20 | 0.660 |
Why?
|
| Adenoma | 1 | 2020 | 68 | 0.650 |
Why?
|
| Calcinosis | 1 | 2020 | 84 | 0.630 |
Why?
|
| Mammary Glands, Human | 2 | 2019 | 56 | 0.270 |
Why?
|
| Hyperplasia | 3 | 2023 | 90 | 0.270 |
Why?
|
| Breast | 3 | 2024 | 190 | 0.260 |
Why?
|
| Biopsy, Large-Core Needle | 2 | 2023 | 22 | 0.240 |
Why?
|
| Surgical Oncology | 1 | 2025 | 6 | 0.230 |
Why?
|
| Lymphoma, B-Cell | 1 | 2005 | 61 | 0.230 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2005 | 63 | 0.220 |
Why?
|
| Sentinel Lymph Node | 1 | 2025 | 12 | 0.220 |
Why?
|
| Nipples | 2 | 2023 | 14 | 0.220 |
Why?
|
| Personnel Selection | 1 | 2025 | 57 | 0.220 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2025 | 39 | 0.220 |
Why?
|
| Lymph Node Excision | 1 | 2025 | 45 | 0.220 |
Why?
|
| Mastectomy, Segmental | 1 | 2025 | 48 | 0.210 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 106 | 0.210 |
Why?
|
| Interviews as Topic | 1 | 2025 | 529 | 0.190 |
Why?
|
| Precancerous Conditions | 1 | 2023 | 74 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2024 | 156 | 0.190 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2022 | 16 | 0.180 |
Why?
|
| Cicatrix | 1 | 2022 | 62 | 0.180 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 39 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 348 | 0.180 |
Why?
|
| Female | 12 | 2025 | 33765 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2022 | 417 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2025 | 6811 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 369 | 0.140 |
Why?
|
| Macrophages | 1 | 2024 | 1048 | 0.140 |
Why?
|
| Mammography | 1 | 2020 | 290 | 0.140 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 61 | 0.140 |
Why?
|
| Phenols | 1 | 2018 | 77 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 669 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2025 | 810 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2024 | 922 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2025 | 1311 | 0.130 |
Why?
|
| Humans | 13 | 2025 | 64778 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 83 | 0.130 |
Why?
|
| Transcriptome | 1 | 2019 | 396 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 605 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2017 | 394 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1633 | 0.090 |
Why?
|
| Middle Aged | 6 | 2025 | 18112 | 0.070 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2009 | 6 | 0.070 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2009 | 7 | 0.070 |
Why?
|
| Adult | 5 | 2025 | 17243 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2005 | 194 | 0.060 |
Why?
|
| Lymphedema | 1 | 2025 | 7 | 0.060 |
Why?
|
| Biopsy | 1 | 2005 | 454 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 556 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 85 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 91 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 350 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 99 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2023 | 335 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 856 | 0.040 |
Why?
|
| Mastectomy | 1 | 2018 | 56 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 221 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 11100 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 160 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 135 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 14 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2751 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2017 | 21 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 59 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 2363 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 426 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 323 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 299 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 522 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 792 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 14840 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1210 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 5565 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2152 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1468 | 0.030 |
Why?
|
| Animals | 2 | 2024 | 21310 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 1231 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2277 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3753 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 3148 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 161 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2009 | 321 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4773 | 0.020 |
Why?
|
| Male | 1 | 2025 | 30812 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 793 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1220 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 1550 | 0.010 |
Why?
|